Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6


Cell-based antiviral screening against coronaviruses: developing virus-specific and broad-spectrum inhibitors.

Kilianski A, Baker SC.

Antiviral Res. 2014 Jan;101:105-12. doi: 10.1016/j.antiviral.2013.11.004. Epub 2013 Nov 20. Review.


The spike protein of SARS-CoV--a target for vaccine and therapeutic development.

Du L, He Y, Zhou Y, Liu S, Zheng BJ, Jiang S.

Nat Rev Microbiol. 2009 Mar;7(3):226-36. doi: 10.1038/nrmicro2090. Epub 2009 Feb 9. Review.


Peptide mimicrying between SARS coronavirus spike protein and human proteins reacts with SARS patient serum.

Hwa KY, Lin WM, Hou YI, Yeh TM.

J Biomed Biotechnol. 2008;2008:326464. doi: 10.1155/2008/326464.


Difference in receptor usage between severe acute respiratory syndrome (SARS) coronavirus and SARS-like coronavirus of bat origin.

Ren W, Qu X, Li W, Han Z, Yu M, Zhou P, Zhang SY, Wang LF, Deng H, Shi Z.

J Virol. 2008 Feb;82(4):1899-907. Epub 2007 Dec 12.


Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection.

Cheng VC, Lau SK, Woo PC, Yuen KY.

Clin Microbiol Rev. 2007 Oct;20(4):660-94. Review.

Supplemental Content

Support Center